A Whole-Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat-Reference-Cited by-同舟云学术

A Whole-Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat

Published:2018-06-08 Issue:4 Volume:123 Page:407-422
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Bouchene Salim¹,Marchand Sandrine²³,Couet William²³,Friberg Lena E.¹,Gobin Patrice²,Lamarche Isabelle²,Grégoire Nicolas²³,Björkman Sven¹,Karlsson Mats O.¹

Affiliation:

1. Department of Pharmaceutical Biosciences; Uppsala University; Uppsala Sweden

2. INSERM U-1070; Pôle Biologie Santé; Poitiers France

3. Laboratoire de Toxicologie et Pharmacocinétique; CHU de Poitiers; Poitiers France

Funder

Stiftelsen för Strategisk Forskning

AIDA Project

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcpt.13026/fullpdf

Reference52 articles.

1. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?;Tran;Int J Antimicrob Agents,2016

2. Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill;Mohamed;Antimicrob Agents Chemother,2012

3. Colistin population pharmacokinetics after application of a loading dose of 9 MU colistin methanesulfonate in critically ill patients;Karaiskos;Antimicrob Agents Chemother,2015

4. Dosing guidance for intravenous colistin in critically-ill patients;Nation;Clin Infect Dis,2017

5. Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS;Jansson;J Pharm Biomed Anal,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying combined effects of colistin and ciprofloxacin against Escherichia coli in an in silico pharmacokinetic-pharmacodynamic model;Scientific Reports;2024-05-22

2. Development of UPLC-MS/MS method for the determination of colistin in plasma and kidney and its application in pharmacokinetics;Journal of Pharmaceutical and Biomedical Analysis;2023-09

3. Controlling factors and toxicokinetic modeling of antibiotics bioaccumulation in aquatic organisms: A review;Critical Reviews in Environmental Science and Technology;2022-11-11

4. Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling;Clinical Pharmacokinetics;2022-08-10

5. Pharmacokinetics and Pharmacodynamics of Colistin Combined With Isopropoxy Benzene Guanidine Against mcr-1-Positive Salmonella in an Intestinal Infection Model;Frontiers in Microbiology;2022-05-20